tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Robert Marcus, 9 are a HOLD (20%), 36 are a BUY (80%).
Analyst Robert Marcus, currently employed at JPMORGAN, carries an average stock price target met ratio of 40% that have a potential upside of 15.92% achieved within 135 days.
Robert Marcus’s has documented 10 price targets and ratings displayed on 1 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on PEN, Penumbra at 23-Feb-2022.
Analyst best performing recommendations are on PEN (PENUMBRA).
The best stock recommendation documented was for PEN (PENUMBRA) at 5/30/2019. The price target of $170 was fulfilled within 41 days with a profit of $23.7 (16.2%) receiving and performance score of 3.95.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
$245
$-21.97 (-8.23%)
$200
1 months 21 days ago
(11-Dec-2024)
21/23 (91.3%)
$-12.92 (-5.01%)
209
Buy
$323
$56.03 (20.99%)
$235
1 months 23 days ago
(09-Dec-2024)
21/24 (87.5%)
$84.72 (35.55%)
74
Buy
$270
$3.03 (1.13%)
$234
2 months 6 days ago
(26-Nov-2024)
17/18 (94.44%)
$25.47 (10.42%)
109
Buy
$250
$-16.97 (-6.36%)
$235
2 months 12 days ago
(20-Nov-2024)
8/10 (80%)
$12.89 (5.44%)
54
Buy
$248
$-18.97 (-7.11%)
$180
3 months 1 days ago
(31-Oct-2024)
10/17 (58.82%)
$19.13 (8.36%)
90
What Year was the first public recommendation made by Robert Marcus?
